// App-Quantinova.ai

: The risk of hyperkalemia in COPD and asthma patients

Researchers

Presenter

  • Jukka Menp

Principal Investigators

  • Ulrika Emerath

  • Stefan Sultana

  • Marita Olsson

  • Mats Carlsson

Medical Centers

  • AstraZeneca, Gothenburg, Sweden

Locations

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Hyperkalemia

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A